New Hampshire SB 256: establishing safety and care requirements for clinician-administered drugs.

Status: Executive Session: 10/14/2026 10:00 am GP 229 (as of 2026-10-01)

State: New Hampshire · Session: 2026 · Bill: SB 256

Sponsors: John Michael Potucek

View New Hampshire SB 256 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.